Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent Straight-Forward AXXA Q1FY25 Revenue Summary (with more to come).
AXXA Revenue Generation Summary:
- Exxe Group booked $16.63 million of services revenue during the First Quarter of FY-2025.
- Revenues supplied to each industrial segment are broken down as follows:
- Agriculture: $2.90 million
- Real Estate: $1.14 million
- Automotive: $7.9 million
- Medical: $4.36 million
- Miscellaneous: $0.33 million
AXXA Future Projections:
- Currently anticipates annualized revenues in the range of $70 million in FY-2025 based on reported results and the projected onboarding of new client contracts.
- Currently engaging with prospective clients in the telecommunications sector, anticipated to significantly broaden our market reach and enhance revenues for Exxe Group.
Is SBFM done R/Sing and will the price stay above $3 into 2025? Once I know this I'll be back for a few shares just for the future of Nora Pharma in 2025 and beyond.
Why is this website still active? Nothing new since 2016.
https://www.adaptivem.com/company/
Still not following why you said CCAJ currently has 20 clients with 2-6 more coming each month? Please clarify.
I must have been confused by your first post where you said "The Company currently has a client base of approximately twenty (20) recurring revenue clients. Additionally, the Company expects to garner between two (2) and six (6) new additional clients per month via its relationship with CMA."
Where are the clients coming from and what type of clients are these?
If no operations, how is CCAJ getting clients from CMA?
Thanks. What do they do and what kind of clients does CCAJ get from them?
Do you know what CMA is?
Some news today about Taco Bell expanding use of AI ordering, but doesn't say which software they are using. Either way, looks like more adoption of this technology. I assume SOUN is tracking if not involved.
https://finance.yahoo.com/video/taco-bell-expand-ai-powered-162332525.html
Chief, do you have answers to my prior post?
When will CCAJ report this revenue and what is CMA?
More on the many Aegis investor losses including SBFM:
https://www.linkedin.com/pulse/aegis-capital-farm-to-table-securities-fraud-purveyor-craig-mccann-gjose
A current investigation of Aegis and SBFM:
https://klaymantoskes.com/investigations/sunshine-biopharma-inc-aegis-capital-investor-loss-investigation/
The July RS Info Statements (PRE 14C and DEF 14C) are no longer posted on the SBFM website or Nasdaq! Is this coincidental and/or mean anything?
https://sunshinebiopharma.com/sec-filings/
https://www.nasdaq.com/market-activity/stocks/sbfm/sec-filings?page=1&rows_per_page=14
I thought SBFM got caught doing some fishy business with the the last RS and Warrants. Whey would the Nasdaq panel allow another RS vs. delisting SBFM now?
The only way we'll know about a sustained reversal is if AXXA gets back above $.0015 and continues climbing!
Another laugh earned from your GIFs! Thanks!
Are we om for another RS or can SBFM get back over $1 some other way (see below from the 8K today)?
The last time they did a RS and Warrants seemed a bit shady and the Nasdaq was "concerned" about how they did it.
Item 8.01. Other Events.
On June 28, 2024, Sunshine Biopharma, Inc. (the “Company”) received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”), informing the Company that the Nasdaq Hearings Panel has granted the Company’s request for an exception until August 26, 2024, to regain compliance with Nasdaq’s minimum bid price requirement under Listing Rule 5550(a)(2).
Finally back to "Pink Current Information," but still waiting for resolution of "Shell Risk" status.
https://www.otcmarkets.com/stock/CCAJ/disclosure
What is the potential positive impact of SOUN's recent partnership with Perplexity? Looks like Perplexity is getting a lot of interest/investment from Softbank, so we'll see if that has any impact on SOUN.
See links below.
https://www.soundhound.com/newsroom/press-releases/soundhound-ai-and-perplexity-partner-to-bring-online-llms-to-its-next-gen-voice-assistants-across-cars-and-iot-devices/
https://finance.yahoo.com/news/softbank-invest-search-startup-perplexity-043717472.html
Nice! Makes for a higher percentage gain when this ticker goes back to $.095 over the next year or so!
Don't forget their pipeline of pipedreams: Buyback, increasing revenue, decreasing debt, rebalancing assets, etc., etc., etc.
Can't wait for the next 2 financial reports this summer.
SBFM needs to unwind all the crap deals they did with Aegis to include giving them back their money and canceling 33 Million shares!
Then, they need to get something done with their drug development pipeline.
I know this is a pipedream, but seems to be the only way to fix their mess.
Friday (6/14/2024) is when SBFM had to respond (in writing) to Nasdaq about the additional listing concerns (aka additional deficiency) related to the "alternate cashless exercise" of the Series A Warrants." SBFM needed to present their views about this concern.
So, did they respond? If so, what was the response? Now we wait for a decision on delisting?
From the 6/7/24 8K filing: "The letter has no immediate effect on the listing of the Company’s common stock. The letter serves as a formal notification that the Nasdaq Hearings Panel (the “Panel”) will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market. In that regard, the letter states that the Company should present its views with respect to this additional deficiency to the Panel in writing no later than June 14, 2024."
Thanks again. Funny!
The Nasdaq concern is in the June 7th filing by SBFM (link below) in the first paragraph on page 2.
https://sunshinebiopharma.com/wp-content/uploads/SBFM_8K_20240607.pdf
Any recourse against SBFM and/or Aegis given Nasdaq has concerns about what they did, or is the outcome just delisting?
SBFM is definitely acting like a penny stock and thus belongs back on the OTC after they give back the $18M+ they still have from the bad Aegis deals. Once they are back on the OTC, perhaps they can get back to at least 99 cents!
SOUN is debt free! Good news yesterday!
Hopefully the SEC gets involved now and makes SBFM management return the millions to shareholders that they made off of all these bad deals with Aegis!
Thanks again for the continued AXXA humor pics!
I missed the point of your reference to Florida when I first read it because I wasn't tracking the move, but now I see Florida is their new HQ on the SBFM website.
Another interesting development given they were only HQ'd in NYC for a few months (PR'd 12/04/23: https://sunshinebiopharma.com/assets/press/20231204_SBFM_Press%20Release_Change%20of%20Headquarters.pdf).
I wonder why they didn't PR the Florida move?
More on NVDA's investments in other companies including SOUN:
Nvidia Owns These 4 Stocks. Heres How Theyre Doing. -- Barrons.com
11:37 AM ET 6/8/24 | Dow Jones
Angela Palumbo
Nvidia has been one of the best-performing stocks on Wall Street since 2023, amassing holdings in four companies along the way. So, how have these stocks been doing?
First, a bit of context. Nvidia stock has surged 144% in 2024 and 212% over the last 12 months as investors snapped up shares of the chip making company, whose products are used to power artificial intelligence. In May, Nvidia reported much stronger first-quarter earnings and revenue than Wall Street expected -- and the stock has climbed 27% since then.
According to Nvidia's most recent 13F form filed with the Securities and Exchange Commission, as of March 31, 2024, Nvidia has stakes in four publicly traded companies: Arm Holdings, Nano-X Imaging, Recursion Pharmaceuticals, and SoundHound.
Nvidia declined to comment to Barron's on its holdings.
Nvidia's second largest stake is in Arm Holdings, a U.K.-based chip maker with a $143 billion market capitalization. American depositary receipts of Arm have jumped 82% this year, as semiconductor stocks continue to benefit from investor excitement about the future of AI. Nvidia owns 1,960,784 shares of the company, which are valued at $268.9 million.
News in May that the company has plans to launch its first AI semiconductors in 2025 have also pushed Arm shares higher.
Meanwhile, SoundHound and Nano-X stocks are having their best years on record, jumping 119% and 23% in 2024, respectively. Nvidia owns 1,730,883 shares of SoundHound -- an AI voice technology company with a $1.6 billion market cap -- which are valued at $8.34 million. SoundHound has also benefited from the AI investing frenzy.
As for Nano-X, Nvidia owns 59,632 shares of the medical imaging systems developer, which are worth $483,019. Nano-X, which has a $468 million market cap, announced on Wednesday that it has launched an AI functionality into its Second Opinions online medical consultation, a platform that connects patients with radiologists for additional consultations on their medical diagnoses. The AI technology is intended to promote early detections of chronic conditions on chest and abdominal CT scans, according to a company news release.
Out of the four companies Nvidia invests in, the chip maker's largest stake is in Recursion Pharmaceuticals, owning 7,706,363 shares that are valued at $69.4 million. Recursion is a clinical-stage biotechnology company with a $2.1 billion market cap.
Unlike the other holdings, Recursion stock has dropped 13% to $8.61 this year -- and is on pace to have its worst year since 2022, according to Dow Jones Market Data. Recursion announced in July 2023 that Nvidia had invested in the company as they work toward developing drugs with the help of AI.
Interesting info in those posts. If this part (pasted below) happens then should be interesting as to what happens to the PPS:
"An unappreciated BULLISH outcome is that Nasdaq will NOT allow further reverse splits, which I predicted and called as the (only) real bear case cuz it'd allow continuation of dilution and exercise price manipulation. That fear has now been eliminated.
If company wants to stay listed on Nasdaq, those warrant terms must be scrapped and I think related dilution will also be remediated, such as canceling those warrants and warrant shares. "
What I meant is that we are in the 6th month of 2024. Does that work?
Take a look at today's AH drop and the SBFM filing today. Does this change your opinion? Is it legal how they did the Series A warrants issued in February 2024?
I wondered why SBFM went way down AH. Looks like it is based on a Nasdaq notification received today and subsequent 8K filed by SBFM. Below is the link to the filing today. Is this legal?
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
https://sunshinebiopharma.com/wp-content/uploads/SBFM_8K_20240607.pdf
We are now 6 months into 2024 so I'm revising my prediction/outlook for AXXA PPS. I now believe/think AXXA will rise from the ashes sometime between July 2024 and June 2025!
GL to anyone who sticks it out that long to find out!
Are you saying "pumpers" are fired, disgruntled ex-employees of AXXA? That has been said about "bashers" so now I'm confused!
Your pictures and video clips always paint a good picture of the point you're making. Thanks.
It seems to be taking a long time to clear up the "Shell Risk" after the Attorney letter on 4/26/24. How long does it take FINRA to make a decision?